Rasimo Lifesciences Private Limited

Rasimo Lifesciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U51909TG2020PTC144973 Incorporated 17 October 2020 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹5.84 Cr
▲ 75% YoY
Net profit · FY 2024
₹5.84 Lakh
Net margin 1%
EBITDA · FY 2024
₹13.45 Lakh
EBITDA margin 2.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered

About Rasimo Lifesciences Private Limited

Data last updated:

Rasimo Lifesciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 October 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2020PTC144973. Its GSTIN is 36AAKCR5281P1ZK (Telangana).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Kamrudin Kurbanali Meghani and Sadiq Shoukatali Surani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2024, the company reported a revenue of ₹5.84 Cr, a growth of 75% compared to the previous year. For the same year it recorded a net profit of ₹5.84 Lakh (net margin 1%) and EBITDA of ₹13.45 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 244% over three years.

The company is associated with 1 brand: Jana-gen.

Rasimo Lifesciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0072185). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909TG2020PTC144973
Registration Number 144973
Incorporation Date 17 October 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0072185

Recognitions & Rankings of Rasimo Lifesciences

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-02-0072185

Contact details

Rasimo Lifesciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    16 – 11 – 511/D/404, Ground And First Floor Moosarambagh, Hyderabad, Telangana, India – 500036
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Rasimo Lifesciences Private Limited, buy the company report.

Comprehensive company report
Rasimo Lifesciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Rasimo Lifesciences operates one associated brand: Jana-gen. Each brand links to its own profile.

BrandDescriptionWebsite
Provides affordable generic medicines through online ordering, home delivery, and physical stores.janagen.com

Business activity

The main business activity of Rasimo Lifesciences is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Rasimo Lifesciences Private Limited, buy the company report.

Financials of Rasimo Lifesciences Private Limited

FY 2025 filings available

Rasimo Lifesciences Private Limited reported revenue of ₹5.84 Cr (up 75% YoY) for FY 2024.

Revenue · FY 2024
₹5.84 Cr ▲ 75%
Net profit · FY 2024
₹5.84 Lakh margin 1%
EBITDA · FY 2024
₹13.45 Lakh margin 2.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 75%
3 years · compounded
▲ 244%
EBITDA CAGR growth
1 year
▲ 117%
3 years · compounded
▲ 52%

Revenue has grown at a compounded annual rate (CAGR) of 244% over three years, including 75% growth in the latest year. EBITDA rose 117% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹13.45 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.84 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.3%
Net Profit Margin1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rasimo Lifesciences Private Limited, buy the company report.

Board of directors of Rasimo Lifesciences Private Limited

Rasimo Lifesciences has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kamrudin Kurbanali MeghaniDirector14 Oct 20233 Years 1 MonthsCurrent
Sadiq Shoukatali SuraniDirector14 Oct 20233 Years 1 MonthsCurrent
Sikander ManjyaniDirector17 Oct 20206 Years 1 MonthsCurrent
Moin PanjwaniDirector17 Oct 20206 Years 1 MonthsCurrent

Auditor

Rasimo Lifesciences Private Limited is audited by NNVANDASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
NNVANDASSOCIATESFY 2022004824S

Shareholding

The shareholding of Rasimo Lifesciences Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rasimo Lifesciences Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rasimo Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Rasimo Lifesciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAKCR5281P1ZKTelanganaActive28 Oct 2020

To see the full GST registrations and return filing status of Rasimo Lifesciences Private Limited, buy the company report.

Recent activity

Rasimo Lifesciences Private Limited has 7 board changes on record since 2020: 4 appointments and 3 cessations. The latest: Kamrudin Kurbanali Meghani ceased to be Additional Director on 29 Sep 2024.

AGM
Rasimo Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rasimo Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Kamrudin Kurbanali Meghani ceased to be Additional Director.
Ceased
Sadiq Shoukatali Surani ceased to be Additional Director.
Appointed
Kamrudin Kurbanali Meghani was appointed as Director.
Appointed
Sadiq Shoukatali Surani was appointed as Director.
Ceased
Rahim Mohammed Samnani ceased to be Director.
Appointed
Moin Panjwani was appointed as Director.
Appointed
Sikander Manjyani was appointed as Director.
Incorporation
17 Oct 2020
Rasimo Lifesciences Private Limited was registered on 17 Oct 2020 with Roc Hyderabad & aged 6 years 1 month as per MCA records.

Frequently asked questions

Rasimo Lifesciences is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 October 2020 (6+ years old) and is registered under CIN U51909TG2020PTC144973.

Rasimo Lifesciences has 4 current directors:

The latest financial statements of Rasimo Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Rasimo Lifesciences is 36AAKCR5281P1ZK, registered in Telangana.

The CIN (Corporate Identification Number) of Rasimo Lifesciences is U51909TG2020PTC144973. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rasimo Lifesciences was incorporated on 17 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.

Kamrudin Kurbanali Meghani ceased to be Additional Director on 29 Sep 2024. Sadiq Shoukatali Surani ceased to be Additional Director on 29 Sep 2024. Kamrudin Kurbanali Meghani was appointed as Director on 14 Oct 2023. Rasimo Lifesciences has 7 board changes on record in total.

Yes, Rasimo Lifesciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0072185).

The registered office of Rasimo Lifesciences is at 16 – 11 – 511D404, Ground And First Floor Moosarambagh, Hyderabad, Telangana, India – 500036.

Rasimo Lifesciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.